Strongyloidiasis Treatment
Ivermectin 200 μg/kg as a single oral dose is the preferred treatment for uncomplicated strongyloidiasis, with a second dose given 2 weeks later for patients with immunosuppression or severe disease. 1
Standard Treatment Regimen
For uncomplicated strongyloidiasis:
- Ivermectin 200 μg/kg orally as a single dose is first-line therapy
- Consider a second dose 2 weeks later to ensure complete eradication, particularly in immunocompromised patients 2
The evidence strongly supports ivermectin over albendazole. A high-quality randomized trial demonstrated parasitological cure rates of 96.8% with single-dose ivermectin versus only 63.3% with 7-day high-dose albendazole (800 mg daily) 2. Recent data from Vietnam confirms that ivermectin 200 μg/kg/day for 2 consecutive days achieved 95.2% overall effectiveness 3.
Severe/Disseminated Disease
For hyperinfection syndrome or disseminated strongyloidiasis:
- Ivermectin 200 μg/kg daily until larvae clearance (typically 14+ days)
- Add albendazole 400 mg daily for combination therapy 4
- Monitor stool samples every 2 weeks until negative
- Consider subcutaneous ivermectin if oral absorption is compromised by paralytic ileus or severe malabsorption 5
Critical Pitfall: Corticosteroid Use
Never initiate corticosteroids in patients with suspected strongyloidiasis without first treating the infection, as steroids trigger hyperinfection syndrome 1. If steroids are already being administered, treat strongyloidiasis urgently before continuing immunosuppression.
Monitoring and Follow-up
- Repeat stool examination at 1 month, 3 months, 6 months, and 1 year post-treatment 2
- Use combination of direct microscopy, formol-ether concentration, and modified Koga agar plate culture for optimal sensitivity
- Serological IgG antibody testing can assess treatment response 3
- Eosinophil counts typically normalize after successful treatment
Special Populations
Immunocompromised patients (diabetes, HIV, HTLV-1, malignancy, organ transplant):
- Always use double-dose regimen (2 doses, 2 weeks apart) as single-dose cure rates may be inadequate 2
- Consider prophylactic treatment before initiating immunosuppression in endemic area residents 4
Pregnancy/Lactation:
- Ivermectin has very low breastmilk excretion and is likely compatible with breastfeeding 1
Alternative Therapy
Albendazole monotherapy is not recommended as first-line due to inferior efficacy (63% cure rate vs 97% with ivermectin) 2. Reserve albendazole for combination therapy in severe disease only.